Records 1 - 30
| Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population.
BMC medical genetics 2019 Sep 20 (1): 148.
Al-Eitan Laith N, Rababa'h Doaa M, Alghamdi Mansour A, Khasawneh Rame
| Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer.
Oncotarget 2017 Nov 8 (59): 100296-100311.
Woo Hye In, Lee Se Kyung, Kim Jiyoung, Kim Seok Won, Yu Jonghan, Bae Soo Youn, Lee Jeong Eon, Nam Seok Jin, Lee Soo-Yo
| Clinical Pharmacokinetics of Vemurafenib.
Clinical pharmacokinetics 2017 Mar .
Zhang Weijiang, Heinzmann Dominik, Grippo Joseph
| The associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China.
Oncotarget 2017 Mar .
Bai Xianan, Xie Jingjing, Sun Shanshan, Zhang Xianyu, Jiang Yongdong, Pang
| Association of CYP450 single nucleotide polymorphisms with the efficacy of epidural ropivacaine during mastectomy.
Acta anaesthesiologica Scandinavica 2015 May 59 (5): 640-7.
Liu J, Xi H, Jiang Y, Feng Z, Hou L, Li
| A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.
Breast cancer research : BCR 2015 17 (1): 110.
Rudolph Anja, Fasching Peter A, Behrens Sabine, Eilber Ursula, Bolla Manjeet K, Wang Qin, Thompson Deborah, Czene Kamila, Brand Judith S, Li Jingmei, Scott Christopher, Pankratz V Shane, Brandt Kathleen, Hallberg Emily, Olson Janet E, Lee Adam, Beckmann Matthias W, Ekici Arif B, Haeberle Lothar, Maskarinec Gertraud, Le Marchand Loic, Schumacher Fredrick, Milne Roger L, Knight Julia A, Apicella Carmel, Southey Melissa C, Kapuscinski Miroslav K, Hopper John L, Andrulis Irene L, Giles Graham G, Haiman Christopher A, Khaw Kay-Tee, Luben Robert, Hall Per, Pharoah Paul D P, Couch Fergus J, Easton Douglas F, Dos-Santos-Silva Isabel, Vachon Celine, Chang-Claude Jen
| Breast Cancer Association with CYP1A2 Activity and Gene Polymorphisms--a Preliminary Case-control Study in Tunisia.
Asian Pacific journal of cancer prevention : APJCP 2015 16 (8): 3559-63.
Imene Ayari, Maurice Arnaud J, Arij Mani, Sofia Pavanello, Saad Sagu
| Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers.
Current drug metabolism 2015 16 (10): 850-63.
He Xin, Feng Sh
| Variants of estrogen-related genes and breast cancer risk in European and African American women.
Endocrine-related cancer 2014 21 (6): 853-64.
Quan Lei, Hong Chi-Chen, Zirpoli Gary, Roberts Michelle R, Khoury Thaer, Sucheston-Campbell Lara E, Bovbjerg Dana H, Jandorf Lina, Pawlish Karen, Ciupak Gregory, Davis Warren, Bandera Elisa V, Ambrosone Christine B, Yao So
| Pharmacogenomics variation in drug metabolizing enzymes and transporters in relation to docetaxel toxicity in Lebanese breast cancer patients: paving the way for OMICs in low and middle income countries.
Omics : a journal of integrative biology 2013 Jul 17 (7): 353-67.
Awada Zainab, Haider Syed, Tfayli Arafat, Bazarbachi Ali, El-Saghir Nagi S, Salem Ziad, Shamseddine Ali, Taher Ali, Zgheib Nathalie Khouei
| Role of CYP1A2 1F polymorphism in cancer risk: evidence from a meta-analysis of 46 case-control studies.
Gene 2013 Jul 524 (2): 168-74.
Tian Zhong, Li Yi-Ling, Zhao Lin, Zhang Chen-Lia
| Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status.
Cancer causes & control : CCC 2013 May 24 (5): 929-40.
Simonsson Maria, Söderlind Viktoria, Henningson Maria, Hjertberg Maria, Rose Carsten, Ingvar Christian, Jernström Hele
| High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype.
Nutrition and cancer 2013 65 (3): 398-409.
Lowcock Elizabeth C, Cotterchio Michelle, Anderson Laura N, Boucher Beatrice A, El-Sohemy Ahm
| Polymorphisms in xenobiotic metabolizing genes, intakes of heterocyclic amines and red meat, and postmenopausal breast cancer.
Nutrition and cancer 2013 65 (8): 1122-31.
Lee Hae-Jeung, Wu Kana, Cox David G, Hunter David, Hankinson Susan E, Willett Walter C, Sinha Rashmi, Cho Eunyou
| Role of CYP1A2 polymorphisms in breast cancer risk in women.
Molecular medicine reports 2012 Nov .
Ayari I, Fedeli U, Saguem S, Hidar S, Khlifi S, Pavanello S
| Genetic polymorphism of estrogen metabolizing enzymes in Siberian women with breast cancer.
Genetic testing and molecular biomarkers 2012 Mar 16 (3): 167-73.
Khvostova Ekaterina P, Pustylnyak Vladimir O, Gulyaeva Lyudmila
| Polymorphism of xenobiotic-metabolizing genes and breast cancer susceptibility in North Indian women.
Genetic testing and molecular biomarkers 2011 May 15 (5): 343-9.
Singh Virendra, Upadhyay Ghanshyam, Rastogi Neeraj, Singh Kalpana, Singh Mahendra Prat
| Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
Breast cancer research and treatment 2010 Jan 119 (2): 463-74.
Authors are not available
| Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
Breast cancer research and treatment 2010 Jan .
Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC
| Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.
International journal of cancer. Journal international du cancer 2009 Aug 125 (4): 837-43.
Sangrajrang Suleeporn, Sato Yasunori, Sakamoto Hiromi, Ohnami Sumiko, Laird Nan M, Khuhaprema Thiravud, Brennan Paul, Boffetta Paolo, Yoshida Teruhi
| Genetic polymorphisms in estrogen metabolism and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians.
Journal of human genetics 2009 Apr 54 (4): 209-15.
Shimada Naoki, Iwasaki Motoki, Kasuga Yoshio, Yokoyama Shiro, Onuma Hiroshi, Nishimura Hideki, Kusama Ritsu, Hamada Gerson Shigeaki, Nishimoto Ines Nobuko, Iyeyasu Hirofumi, Motola Juvenal, Laginha Fábio Martins, Kurahashi Norie, Tsugane Shoichi
| Coffee intake and CYP1A2*1F genotype predict breast volume in young women: implications for breast cancer.
British journal of cancer 2008 Nov 99 (9): 1534-8.
Jernström H, Henningson M, Johansson U, Olsson
| Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Apr 17 (4): 895-901.
Bågeman Erika, Ingvar Christian, Rose Carsten, Jernström Hele
| Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
Pharmacogenetics and genomics 2007 May 17 (5): 331-8.
Long Ji-Rong, Cai Qiuyin, Shu Xiao-Ou, Cai Hui, Gao Yu-Tang, Zheng W
| The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 May 16 (5): 912-6.
Kotsopoulos Joanne, Ghadirian Parviz, El-Sohemy Ahmed, Lynch Henry T, Snyder Carrie, Daly Mary, Domchek Susan, Randall Susan, Karlan Beth, Zhang Phil, Zhang Shiyu, Sun Ping, Narod Steven
| Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Mar 16 (3): 444-50.
Rebbeck Timothy R, Troxel Andrea B, Walker Amy H, Panossian Saarene, Gallagher Stephen, Shatalova Ekaterina G, Blanchard Rebecca, Norman Sandra, Bunin Greta, DeMichele Angela, Berlin Michelle, Schinnar Rita, Berlin Jesse A, Strom Brian
| Breast density and polymorphisms in genes coding for CYP1A2 and COMT: the Multiethnic Cohort.
BMC cancer 2007 7 (): 30.
Takata Yumie, Maskarinec Gertraud, Le Marchand Lo
| Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
Pharmacogenetics and genomics 2006 Apr 16 (4): 237-43.
Long Ji-Rong, Egan Kathleen M, Dunning Lisa, Shu Xiao-Ou, Cai Qiuyin, Cai Hui, Dai Qi, Holtzman Jordan, Gao Yu-Tang, Zheng W
| Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Aug 14 (8): 1998-2003.
Le Marchand Loïc, Donlon Timothy, Kolonel Laurence N, Henderson Brian E, Wilkens Lynne
| Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and postmenopausal women in Ontario, Canada.
The breast journal 0 20 (5): 468-80.
Cotterchio Michelle, Mirea Lucia, Ozcelik Hilmi, Kreiger Nan